Stock screener

IOVA

Conviction 83HealthcareScan · Mon, Aug 10, 2026
IOVA$6.39+0.79%
ResistanceSupportVol 14
63 bars
Vol MA14 19.4M
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest -80.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
IOVANCE BIOTHERAPEUTICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.iovance.com ↗
Price6.39
Change+0.79%
Gap-1.42%
Rel volume1.13×
Avg volume20.85M
Avg $ vol108.35M
SMA 204.95
SMA 504.45
SMA 2003.39
Price vs 50+43.75%
Price vs 200+88.45%
MA stackbullish
50/200 cross—
Supertrendup · 4.68
RSI (14)71
MACD hist0.16
MACD crossbull · 2d
Stoch %K / %D82 / 85
ADX (14)26
+DI / −DI41 / 13
RSI divergence—
MACD divergence—
ATR %+8.12%
ADR %9.03%
52w high6.39
52w low1.81
From 52w high+0.00%
Above 52w low+253.04%
New 52w highYes
SqueezeOff
Bollinger width55.15%
%B1.03
Donchian pos83.23%
Donchian high6.92
Donchian low3.76
AVWAP (52w high)6.38
vs AVWAP high+0.11%
AVWAP (52w low)3.64
vs AVWAP low+75.47%
OBV trendUp
Chaikin MF (20)0.06
Today vs 20d1.13×
Avg vol (14d)19.4M
Avg vol (20d)20.85M
Avg $ vol (20d)108.35M
Market cap—
RS 3m (vs SPY)+72.89%
RS 6m (vs SPY)+154.53%
RS line new highYes
Trend template8/8
Technical rank97.1
1 week+48.09%
1 month+51.06%
3 months+76.52%
6 months+152.57%
1 year+142.05%
YTD+153.57%
P/E-7.34
P/B3.90
P/S10.89
P/FCF-8.53
EPS-1.09
Div yield—
ROE-53.12%
ROA-42.71%
Debt/Eq—
Current4.34
EV/EBITDA-7.06
Gross margin—
Net margin-148.38%
Rev growth60.60%
EPS growth-5.05%
Price target8.83
Target upside39.38%
Analyst ratingBuy
Institutional70.22%
Ent. value2.76B
Revenue99.31M
Net income-47.31M
Gross profit—
Free cash flow-336.24M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out446.5M
Employees975
ListedWed, May 26, 2010
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction83 / 100
Pattern quality—
Tech rank97.1 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance5.39
Support3.78
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IOVA

All disclosures →
No recent disclosed trades by Congress in IOVA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IOVA · 6 buys · 4 sells

InsiderSideShares
Countouriotis Athena
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
Dukes Iain D.
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant180.63K
Puri Raj K.
Chief Regulatory Officer · Restricted Stock Units · 2026-06-16
Grant15K
Maynard Ryan D
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
WEISER MICHAEL
Director · Deferred Restricted Stock Unit · 2026-06-16
Grant90.32K
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer · Restricted Stock Units · 2026-06-05
Exercise7.81K
Vogt Frederick G
Interim CEO & General Counsel · Restricted Stock Units · 2026-06-05
Exercise15.63K
Puri Raj K.
Chief Regulatory Officer · Common Stock · 2026-06-05
Tax3.84K
BILINSKY IGOR
Chief Operating Officer · Common Stock · 2026-06-05
Exercise7.81K
GRAF FINCKENSTEIN FRIEDRICH
Chief Medical Officer · Common Stock · 2026-06-05
Tax3.98K

SEC filings

EDGAR filings in IOVA · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.